EGFR and non-small cell lung carcinoma: In summary, these findings demonstrate that the combination of 10k or 10l with EGFR-TKIs markedly enhances the inhibition of cell proliferation and increases the apoptosis and necrosis in EGFR-TKI resistant NSCLC cell models.